AVOCAMERA LTD

Company number 12626395 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

AVOCAMERA LTD - Analysis Report

Company Number: 12626395

Analysis Date: 2025-07-20 18:48 UTC

Financial Health Assessment for AVOCAMERA LTD (As of 31 May 2024)


1. Financial Health Score: C

Explanation:
AVOCAMERA LTD demonstrates a modest but improving financial position. While the company has managed to increase its net assets from £143 in 2023 to £4,317 in 2024, it still shows signs of tight liquidity and working capital challenges, reflected by negative net current assets in 2024. The company's equity base is very small (£4,317), which limits financial resilience. Overall, the financial "vital signs" suggest a recovering but fragile condition, warranting caution and proactive management.


2. Key Vital Signs

Metric 2024 Value Interpretation
Fixed Assets £8,704 Moderate investment in long-term assets, slightly reduced from prior year indicating asset usage or disposals.
Current Assets £41,443 Sizable short-term resources, mostly cash and debtors.
Cash at Bank £27,349 Healthy cash balance, nearly two-thirds of current assets, indicating good immediate liquidity.
Debtors £14,094 Receivables represent a significant portion; potential cash flow bottleneck if collection is slow.
Current Liabilities £45,830 High short-term obligations exceeding current assets, causing negative net current assets (-£4,387).
Net Current Assets (Working Capital) -£4,387 Negative working capital signals liquidity stress and potential difficulty meeting short-term debts.
Net Assets (Equity) £4,317 Low equity base but improved from previous year, showing incremental value retention.
Share Capital £1 Minimal share capital, typical for small private companies.
Profit & Loss Reserve £4,316 Retained earnings have increased, indicating some profitability or capital injections.

3. Diagnosis: Financial Health Overview

  • Liquidity Status (Healthy Cash Flow? Not Yet Optimal):
    The company holds a substantial cash balance (£27,349), which is a positive "heartbeat" in liquidity terms. However, current liabilities (£45,830) exceed current assets (£41,443), resulting in a negative working capital of £4,387. This "symptom of distress" suggests short-term obligations may strain cash flow despite the cash on hand. Debtor balances are also sizeable, which may delay cash conversion cycles.

  • Asset Utilization and Aging:
    Fixed assets have decreased from £13,870 to £8,704, possibly due to depreciation or disposals, reflecting aging equipment or controlled investment. This could imply the company is cautious in capital expenditure or is facing asset wear without replacement yet.

  • Capital Structure and Resilience:
    The equity base is very slight, with shareholders’ funds of £4,317. The negligible share capital (£1) means the company is almost entirely reliant on retained earnings or external funding for financial stability. This thin "financial skin" means the company can be vulnerable to shocks or unexpected expenses.

  • Profitability (Indirect Insight):
    The increase in profit and loss reserves from £142 to £4,316 indicates some profitable operations or capital contributions, a healthy sign but still at a small scale. The absence of an income statement limits deeper profitability analysis.

  • Going Concern and Operational Status:
    The company is active, not in liquidation or administration, with no overdue filing penalties. Director appointments are current and stable. This suggests the company is operationally sound, though financially still in early growth or recovery.


4. Recommendations: Steps to Improve Financial Wellness

  1. Improve Working Capital Management:

    • Accelerate debtor collections to convert receivables into cash faster, easing liquidity pressure.
    • Negotiate longer payment terms with creditors to better match cash inflows and outflows.
  2. Enhance Profitability and Cash Generation:

    • Review pricing, cost control, and operational efficiencies to increase net profits and cash reserves.
    • Consider diversifying revenue streams within the photographic and video production sector to stabilize income.
  3. Strengthen Capital Base:

    • Inject additional equity or secure longer-term financing to improve the financial "immune system" and build resilience against shocks.
    • Keep adequate reserves to cushion against periods of low cash flow.
  4. Asset Management:

    • Plan for gradual reinvestment in fixed assets to maintain operational capacity and avoid obsolescence.
    • Monitor asset utilization rates and depreciation to optimize capital expenditure.
  5. Financial Monitoring:

    • Establish regular financial health check-ups focusing on liquidity ratios, net assets, and cash flow forecasts to detect early symptoms of financial distress.
    • Maintain timely accounting and compliance to avoid penalties and retain stakeholder confidence.

Medical Analogy Summary

AVOCAMERA LTD's financial "pulse" shows signs of recovery with improved net assets and a healthy cash "heartbeat," but the company is currently experiencing "symptoms" of liquidity strain due to negative working capital. The financial "immune system" is thin with minimal equity buffer, so proactive "treatment" through working capital management, capital strengthening, and profitability improvement is essential to ensure a positive "prognosis" for sustainable growth.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.